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Introduction {#cam4589-sec-0001}
============

Larynx cancer is an important entity of oncology. International data states that larynx cancer accounts for 30--40% of all malignant head and neck tumors [1](#cam4589-bib-0001){ref-type="ref"}, [2](#cam4589-bib-0002){ref-type="ref"}. The highest incidence of laryngeal cancer occurs between the fifth and seventh decade of life [3](#cam4589-bib-0003){ref-type="ref"}, [4](#cam4589-bib-0004){ref-type="ref"}. Larynx cancer is a complex disease that results from the interaction between environmental factors and genetics [5](#cam4589-bib-0005){ref-type="ref"}, [6](#cam4589-bib-0006){ref-type="ref"}, [7](#cam4589-bib-0007){ref-type="ref"}, [8](#cam4589-bib-0008){ref-type="ref"}. Several environmental factors, including smoking, alcohol consumption, exposure to carcinogens in the work environment, nutrition, and viral infections with human papilloma virus (HPV) and Eostein--Barr virus (EBV), contribute to larynx cancer [9](#cam4589-bib-0009){ref-type="ref"}, [10](#cam4589-bib-0010){ref-type="ref"}, [11](#cam4589-bib-0011){ref-type="ref"}. The progress of molecular biology in the analysis and decoding of DNA proved that a number of genes, called oncogenes, are involved in the mechanisms of carcinogenesis in the larynx. Several DNA repair genes, such as *RAD51*,*XRCC2* [12](#cam4589-bib-0012){ref-type="ref"}, *XRCC3* [13](#cam4589-bib-0013){ref-type="ref"}, and *RECQL5* gene [14](#cam4589-bib-0014){ref-type="ref"}, are associated with larynx cancer.

*MLL3* is a member of the TRX/MLL gene family, and it maps to chromosome 7q36.1. *MLL3* encodes a predicted protein of 4911 amino acids that contain two plant homeodomains (PHD), an ATPase alpha/beta signature, a high mobility group, a suppressor of variegation, enhancer of zeste, trithorax (SET), and two FY (phenylalanine tyrosine)‐rich domains. PHD and SET domain proteins are chromatin regulators, and several of them are altered in cancer [15](#cam4589-bib-0015){ref-type="ref"}. Inactivation of MLL3 in mice results in epithelial tumor formation, which suggests that it functions as a tumor‐suppressor gene [16](#cam4589-bib-0016){ref-type="ref"}. Additionally, MLL3 is frequently deleted in myeloid leukemias [17](#cam4589-bib-0017){ref-type="ref"}, [18](#cam4589-bib-0018){ref-type="ref"}, and reports identified somatic mutations in the MLL3 gene in glioblastoma and pancreatic ductal adenocarcinoma [19](#cam4589-bib-0019){ref-type="ref"}. However, the relationship between genetic polymorphisms of MLL3 and larynx cancer is not known.

This study established haplotypes of the *MLL3* gene, which consisted of four SNPs (rs6943984, rs4725443, rs3800836, rs6464211) and assessed the relationship between these SNPs and larynx cancer in a Chinese population.

Material and Methods {#cam4589-sec-0002}
====================

Patients {#cam4589-sec-0003}
--------

The Bioethics Committee of the First Affiliated Hospital of Liaoning Medical University approved this study, and each patient gave written consent. All the participants are Chinese Han population and they are not related to each other. Blood samples were obtained from all subjects, including 592 patients with larynx cancer from the Department of Otolaryngology, the First Affiliated Hospital of Liaoning Medical University from May 2006 to June 2014 and 602 cancer‐free age‐ and sex‐matched controls. Patients ranged in age from 44 to 85 years (64.8 ± 8.5), and the control subjects ranged in age from 45 to 83 years (65.0 ± 9.1). Among the larynx cancer patients, there were 315 cases of grade 1, 215 cases of grade 2, and 62 cases of grade 3 in total. Tumor, lymph node and metastasis (TNM) staging indicated that there were 166 cases of stage I, 130 cases of stage II, 201 cases of stage III, 78 cases of stage IVA, and 17 cases of stage IVB.

Definition of smoking and drinking {#cam4589-sec-0004}
----------------------------------

As described in pervious study [20](#cam4589-bib-0020){ref-type="ref"}, persons reporting regular tobacco use in the previous 6 months were considered as current users. Persons who were ingesting alcohol in the last 6 months were considered to be alcohol users.

Genotyping {#cam4589-sec-0005}
----------

There are 8070 SNPs for the human MLL3 gene listed in the National Center for Biotechnology Information SNP database (<http://www.ncbi.nlm.nih.gov/SNP>). We also screened data for the Tag SNPs in the International HapMap Project website (<http://www.hapmap.org/>). We used Haploview 4.2 software (Harvard University, Cambridge, MA, USA) and the HapMap phase II database obtained four tagging SNPs \[rs6943984 (g.152201919G\>A), rs4725443 (g.152170176T\>C), rs3800836 (g.152149985C\>T), rs6464211(g.152176768C\>T)\] for the Chinese Han subjects using a minor allele frequency (MAF) ≥ 0.05 and linkage disequilibrium patterns with *r* ^2^ ≥ 0.8 as a cutoff. Figure [1](#cam4589-fig-0001){ref-type="fig"} shows that these four SNPs were located in one haplotype block.

![Genetic variations in the human *MLL3* gene. Using Haploview 4.2 software and the HapMap phrase II database, we scanned 53‐genotyped single‐nucleotide polymorphisms (SNPs) in Chinese Han. Linkage disequilibrium (LD) blocks across the locus in Chinese Han. LD block derived using the solid spline method in Haploview 4.2. LD values are shown: (A) \|D′\| × 100; \|D′\| color scheme: \|D′\| = 0: white; 0 \< \|D′\| \< 1: shades of pink; \|D′\| = 1: red; (B) *r* ^2^ × 100; *r* ^2^ color scheme: *r* ^2^ = 0: white; 0 \< *r* ^2^ \< 1: shades of gray; *r* ^2^ = 1: black.](CAM4-5-527-g001){#cam4589-fig-0001}

Genomic DNA was extracted from peripheral blood leukocytes using a DNA extraction kit (Beijing Bioteke Co. Ltd. Beijing, China). Genotyping was performed using the TaqMan^®^ SNP Genotyping Assay (Applied Biosystems Inc., Foster City, CA, USA) as described previously [20](#cam4589-bib-0020){ref-type="ref"}. Two researchers without the knowledge of case or control status blindly conducted all assays. Additionally, approximately 10% of the samples were randomly selected and retested, and the results were 100% concordant.

Statistical analysis {#cam4589-sec-0006}
--------------------

SPSS 17.0 (Chicago, IL, USA) for Windows was used for statistical analyses. Hardy--Weinberg equilibrium was assessed for each polymorphism using standard chi‐square test or Fisher\'s exact test. Genotype frequencies in cases and controls were compared using chi‐square tests. Genotype‐specific risks were estimated as odds ratios (ORs) and 95% CI. We performed linkage disequilibrium (LD) analyses and haplotype‐based case--control analyses based on the genotype data of the genetic variations using SHEsis software (<http://analysis2.bio-x.cn/myAnalysis.php>) [21](#cam4589-bib-0021){ref-type="ref"}, [22](#cam4589-bib-0022){ref-type="ref"}. Haplotypes with a frequency of \<0.03 in the haplotype‐based case--control analyses were excluded. We used a Bonferroni correction to control for the number of variants tested (four) to assess the association of each SNP with laryngeal cancer risk. Therefore, a probability value of 0.0125 was considered to be significant.

Results {#cam4589-sec-0007}
=======

Table [1](#cam4589-tbl-0001){ref-type="table-wrap"} shows the participants\' characteristics. There were significant differences between the case group and the control group in smoking (*P* \< 0.001) and alcohol consumption (*P* \< 0.001), especially in men (*P* \< 0.001).

###### 

Characteristics of study participants

                             Total        Men          Women                                                                   
  -------------------------- ------------ ------------ --------- ------------ ------------ --------- ------------ ------------ -------
  Number of subjects         592          602                    402          411                    190          191          
  Age                        64.8 ± 8.5   65.0 ± 9.1   0.312     65.8 ± 8.8   65.3 ± 9.0   0.543     63.7 ± 8.9   64.0 ± 9.1   0.612
  Smoking                    431 (72.8)   243 (40.4)   \<0.001   341 (84.8)   162 (39.4)   \<0.001   90 (47.4)    81 (42.4)    0.006
  Alcohol use                302 (51.0)   234 (38.9)   0.087     246 (61.2)   184 (44.8)   \<0.001   56 (29.5)    50 (26.3)    0.121
  Family history of cancer   69 (11.7)    \_                     32 (7.9)     \_                     37 (19.5)    \_           

Values are given as mean ± SD or *n* (%).
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Table [2](#cam4589-tbl-0002){ref-type="table-wrap"} shows the distribution of the genotypes and alleles of the four studied SNPs. The genotype distribution of each SNP was not significantly different from the Hardy--Weinberg equilibrium values (data not shown). Table [2](#cam4589-tbl-0002){ref-type="table-wrap"} shows that rs6943984 and rs4725443 of the MLL3 gene were significantly associated with the risk of larynx cancer after Bonferroni correction. The minor allele A for rs6943984 was associated with an increased larynx cancer risk (*P* \< 0.001, OR = 1.960, 95% CI = 1.587--2.420). C allele frequency (0.151) for rs4725443 was significantly higher in the case group than the control group (0.072, *P* \< 0.001).

###### 

Genotypes and allele distributions in cases and control subjects

  SNP         Group   *n*           Genotype      [a](#cam4589-note-0003){ref-type="fn"} *P*   Allele        [a](#cam4589-note-0003){ref-type="fn"} *P*   OR (95% CI)                                     
  ----------- ------- ------------- ------------- -------------------------------------------- ------------- -------------------------------------------- -------------- --------- ---------------------- --
  rs6943984                         AA            AG                                           GG                                                         A              G                                
  Cases       592     40 (0.068)    204 (0.345)   348 (0.588)                                  \<0.001       284 (0.240)                                  900 (0.760)    \<0.001   1.960 (1.587--2.420)   
  Control     602     16 (0.027)    135 (0.224)   451 (0.749)                                  167 (0.139)   1037 (0.861)                                                                                 
  rs4725443                         CC            CT                                           TT                                                         C              T                                
  Cases       592     16 (0.027)    147 (0.248)   429 (0.725)                                  \<0.001       179 (0.151)                                  1005 (0.849)   \<0.001   2.287 (1.746--2.995)   
  Control     602     6 (0.010)     75 (0.125)    521 (0.865)                                  87 (0.072)    1117 (0.928)                                                                                 
  rs3800836                         AA            AG                                           GG                                                         A              G                                
  Cases       592     111 (0.188)   290 (0.490)   191 (0.323)                                  0.037         512 (0.432)                                  672 (0.568)    0.091     0.870 (0.740--1.022)   
  Control     602     115 (0.191)   332 (0.551)   155 (0.257)                                  562 (0.467)   642 (0.533)                                                                                  
  rs6464211                         CC            CT                                           TT                                                         C              T                                
  Cases       592     381 (0.644)   194 (0.328)   17 (0.029)                                   0.032         956 (0.807)                                  228 (0.193)    0.035     1.235 (1.014--1.505)   
  Control     602     363 (0.603)   204 (0.339)   35 (0.058)                                   930 (0.772)   274 (0.228)                                                                                  

*P* value indicated the global difference of genotypes or alleles between the case and control groups. OR values refer to the major allele, such as G of rs6943984, T of rs4725443, G of rs3800836, and C of rs6464211.
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Figure [2](#cam4589-fig-0002){ref-type="fig"} shows the patterns of linkage disequilibrium in the MLL3 gene and the \|D′\| (A) and *r* ^2^ values (B). All four SNPs are located in one haplotype block because all \|D′\| are beyond 0.5. All four SNPs were available for the performance of a haplotype‐based case--control study because all of the *r* ^2^ values were below 0.5. The haplotype‐based case--control analyses established haplotypes using four SNPs (Table [3](#cam4589-tbl-0003){ref-type="table-wrap"}). Haplotype analyses showed that haplotypes A‐T‐A‐C and G‐T‐G‐C increased the risk of laryngeal cancer (OR = 2.406, 95% CI: 1.820--3.180, *P* \< 0.001; OR = 1.399, 95% CI: 1.180--1.659, respectively), and haplotypes G‐T‐A‐C and G‐T‐G‐T significantly reduced the risk of laryngeal cancer (OR = 0.332, 95% CI: 0.271--0.408, *P* \< 0.001; OR = 0.742, 95% CI: 0.607--0.908, respectively) (Table [3](#cam4589-tbl-0003){ref-type="table-wrap"}).

![Patterns of linkage disequilibrium in the *MLL3* gene, with their \|D′\| (A) and *r* ^2^ values (B).](CAM4-5-527-g002){#cam4589-fig-0002}

###### 

Haplotype distribution of patients and control subjects

  Haplotypes   Haplotype frequencies   χ^2^             *P*      OR        95% CI   
  ------------ ----------------------- ---------------- -------- --------- -------- --------------
  A C A C      94.71 (0.080)           87.00 (0.072)    0.683    0.408     1.136    0.839--1.538
  A T A C      170.28 (0.144)          79.98 (0.066)    39.843   \<0.001   2.406    1.820--3.180
  G T A C      162.70 (0.137)          395.01 (0.328)   116.79   \<0.001   0.332    0.271--0.408
  G T G C      443.99 (0.375)          367.99 (0.306)   14.969   \<0.001   1.399    1.180--1.659
  G T G T      209.00 (0.177)          273.99 (0.228)   8.463    0.004     0.742    0.607--0.908

Global *χ* ^2^ was 229.25, and df = 5 (frequency \<0.03 in both control and cases was dropped.) Fisher\'s *P* value was 2.22 × 10^−15^.

John Wiley & Sons, Ltd

Table [4](#cam4589-tbl-0004){ref-type="table-wrap"} describes the influence of the combined effects of rs6943984 and rs4725443 with smoking and drinking on the risk of laryngeal cancer. The GG genotype for rs6943984 in the nonsmoking group (used as a reference, OR = 1) demonstrated that the OR for the risk of laryngeal cancer was 2.327 (95% CI: 1.544--3.507, *P* \< 0.001) for carriers of GA + AA. The corresponding OR was 6.679 (95% CI: 4.713--9.466, *P* \< 0.001) in the smoking group, which was significantly higher than the OR value obtained by multiplying the risks of laryngeal cancer associated with smoking and the genetic polymorphisms that were obtained in the univariate analyses. Similarly, using the GG genotype and the nondrinking group as a reference (OR = 1), the OR for the risk of laryngeal cancer was 2.175 (95% CI: 1.582--2.989, *P* \< 0.001) for carriers of GA + AA in the nondrinking group. The corresponding OR was 5.024 (95% CI: 3.233--7.806, *P* \< 0.001) in the drinking group, which was significantly higher than the OR value that was obtained by multiplying the risks of laryngeal cancer associated with drinking and genetic polymorphisms obtained in the univariate analyses.

###### 

Interaction between smoking, drinking, and rs1056827

                GG (TT)   GA + AA (TC + CC)                                                                         
  ------------- --------- ------------------- ---------------------- --------- ----- ----- ------------------------ ---------
  rs6943984                                                                                                         
  Nonsmoking    101       286                 1 (ref.)                         60    73    2.327 (1.544--3.507)     \<0.001
  Smoking       247       165                 4.238 (3.806--6.997)   \<0.001   184   78    6.679 (4.713--9.466)     \<0.001
  Nondrinking   144       251                 1 (ref.)                         146   117   2.175 (1.582--2.989)     0.001
  Drinking      204       200                 1.777 (1.339--2.359)   \<0.001   98    34    5.024 (3.233--7.806)     \<0.001
  rs4725443                                                                                                         
  Nonsmoking    122       306                 1 (ref.)                         39    53    1.845 (1.160--2.934)     0.009
  Smoking       307       215                 3.581 (2.726--4.704)   \<0.001   124   28    11.107 (7.007--17.607)   \<0.001
  Nondrinking   155       295                 1 (ref.)                         135   73    3.519 (2.493--4.968)     \<0.001
  Drinking      274       226                 2.307 (1.775--2.999)   \<0.001   28    8     6.661 (2.965--14.965)    \<0.001
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Using the TT genotype for rs4725443 in the nonsmoking group as a reference (OR = 1), the OR for the risk of laryngeal cancer in the nonsmoking group was 1.845 (95% CI: 1.160--2.934, *P* \< 0.001) for carriers of TC + CC. The corresponding OR in the smoking group was 11.107 (95% CI: 7.007--17.607, *P* \< 0.001), which was significantly higher than the OR value that was obtained by multiplying the risks of laryngeal cancer associated with smoking and the genetic polymorphisms that were obtained in univariate analyses. Similarly, using the TT genotype in the nondrinking group as a reference (OR = 1), the OR for the risk of laryngeal cancer in the nondrinking group was 3.519 (95% CI: 2.493--4.968, *P* \< 0.001) for carriers of TC + CC. The corresponding OR in the drinking group was 6.661 (95% CI: 2.965--14.965, *P* \< 0.001), which was significantly higher than the OR value that was obtained by multiplying the risks of laryngeal cancer associated with drinking and the genetic polymorphisms that were obtained in univariate analyses.

These data indicated that rs6943984 and rs4725443 polymorphisms in the *MLL3* gene had synergistic effects with smoking or alcohol consumption for the risk of laryngeal cancer. However, the other two loci did not exhibit synergistic effects with smoking and drinking (data not shown).

Multivariate analysis suggested that after adjustment of confounders such as age, alcohol use, and family history of cancer, the interaction between smoking and rs6943984 and rs4725443 polymorphisms remains significant (*P* \< 0.05).

Discussion {#cam4589-sec-0008}
==========

This study found *MLL3* gene polymorphisms and haplotypes that were significantly associated with larynx cancer risk in a Chinese population. To the best of our knowledge, this is the first study to reveal associations of *MLL3* genetic polymorphisms with larynx cancer.

It is generally accepted that larynx cancer is a complex, multifactorial, and polygenic disorder that involves multiple simultaneous environmental and genetic factors. The foundation for human studies examining putative causative genes that may be involved in larynx cancer is based on a candidate gene approach. This approach involves the selection of a functionally relevant gene and a subsequent investigation of its association with the larynx cancer phenotype. A few recent studies revealed that MLL3 genetic polymorphisms were associated with human cancer [23](#cam4589-bib-0023){ref-type="ref"}, [24](#cam4589-bib-0024){ref-type="ref"}, [25](#cam4589-bib-0025){ref-type="ref"}, [26](#cam4589-bib-0026){ref-type="ref"}. Our study genotyped four SNPs in the *MLL3* gene in Chinese participants and assessed associations between *MLL3* polymorphisms and larynx cancer using a haplotype‐based case--control analysis. The rs6943984 and rs4725443 distributions differed significantly between larynx cancer patients and control participants. The risk of larynx cancer increased in participants with the A allele of rs6943984 and C allele of rs4725443. We also successfully established haplotypes for the MLL3 gene from the different combinations of the four SNPs. The frequency of the A‐T‐A‐C and G‐T‐G‐C haplotypes was associated with an increased risk for larynx cancer. However, the G‐T‐A‐C and G‐T‐G‐T haplotypes were associated with a decreased risk for larynx cancer.

However, the molecular mechanism related to the association of MLL3 genetic polymorphism and larynx cancer remains unclear. MLL3 is located on chromosome 7q36.1 and has been associated with different types of cancers. MLL3 presents inactivating mutations in medulloblastoma and colorectal cancer [27](#cam4589-bib-0027){ref-type="ref"}. Moreover, it shows reduced expression in primary breast tumor samples [24](#cam4589-bib-0024){ref-type="ref"} and radio‐resistant esophageal cancer cell lines [28](#cam4589-bib-0028){ref-type="ref"}. A recent study showed that exome sequencing identified a germline mutation in MLL3, producing a truncated protein, in a pedigree of colorectal cancer and acute myeloid leukemia [29](#cam4589-bib-0029){ref-type="ref"}. These results suggest that MLL3 acts as a tumor suppressor in cancer development. MLL3 forms a steady‐state complex with ASC‐2, a multifunctional coactivator of nuclear receptors and other transcription factors. This complex called ASCOM interacts with p53 and is required for expression of p53‐target genes in response to DNA damage. These results indicate a role of MLL3 in the DNA damage response pathway through p53 activation [15](#cam4589-bib-0015){ref-type="ref"}. The down regulation of MLL3 in larynx cancer may therefore impair the DNA damage response contributing to the proliferation of cancer cell. However, this hypothesis must be further investigated. This study also indicated that subjects who smoke or consume alcohol had a significantly increased risk of laryngeal cancer. These results further confirm that smoking and alcohol consumption are risk factors for laryngeal cancer. Furthermore, our study of the combined effects of gene polymorphisms and the environment on the risk of laryngeal cancer demonstrated that a combination of effects increased the risk of laryngeal cancer, the combination of genetic and environmental factors demonstrated significant synergistic effects of tobacco and alcohol and *MLL3* polymorphisms.

Conclusion {#cam4589-sec-0009}
==========

In conclusion, the present results indicated that larynx cancer was associated with *MLL3* gene polymorphisms. The A‐T‐A‐C and G‐T‐G‐C haplotypes may be useful genetic risk markers, and the G‐T‐A‐C and G‐T‐G‐T haplotypes might be protective factors of larynx cancer in Chinese people. There was a mutually synergistic effect between smoking, alcohol consumption, and *MLL3* gene polymorphisms for laryngeal cancer.
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